Researcher
Peter Vandenabeele
- Keywords (Ghent University):Cell death and inflammation
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Ghent University):Biophysics, Molecular and cell biology, Laboratory medicine, Microbiology, Systems biology, Plant biology, Medicinal and biomolecular chemistry, Molecular and cell biology not elsewhere classified
Affiliations
- Vandenabeele Lab (Research group)
Responsible
From1 Jan 2017 → Today - Board of Governors/Executive Board (Administrative office)
Member
From1 Oct 2012 → Today - Department of Biomedical molecular biology (Department)
Member
From1 Oct 1993 → Today - Department of Plant Biotechnology and Bioinformatics (Department)
Member
From1 Jan 1993 → 30 Sep 1993
Projects
11 - 20 of 69
- Thymic reprogramming: Systemic inflammation changes the cellular output of the thymus from T cells to NK cells and iron-binding myeloid cellsFrom1 Oct 2020 → 30 Sep 2023Funding: BOF - postdoctoral mandates
- Thymic reprogramming: The role of Death Receptor 3 (DR3)From1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Elucidate the role of death receptor 3 (DR3) in thymic immune activation in infectious diseaseFrom1 Nov 2019 → 31 Oct 2023Funding: FWO fellowships
- Investigating the role of rivers during the Late Glacial recolonization of NW Europe: a multidisciplinary assessment of Final Palaeolithic sites in the Scheldt valley (Belgium)From1 Nov 2019 → 31 Oct 2022Funding: FWO junior postdoctoral fellowship
- Identification of cellular mechanisms of radiotherapy-induced immunogenicityFrom1 Oct 2019 → 29 Feb 2020Funding: BOF - postdoctoral mandates
- Development of a micro-spatially offset Raman spectroscopy (micro-SORS) probe for the in situ characterisation of layered structuresFrom1 Oct 2018 → 30 Sep 2021Funding: FWO fellowships
- MOlecular mechanisms of cellular DEath and Life decisions in Inflammation, Degeneration and InfectionFrom1 Jan 2018 → 31 Dec 2021Funding: FWO EOS
- Investigating the role of ferroptosis in acute liver injury and multiple sclerosis with newly developed chemical tool compoundsFrom1 Jan 2018 → 31 Dec 2021Funding: FWO research project (including WEAVE projects)
- Capacity building of a compound screening facility for Cuban-developed bioactive compounds targeting cell death and inflammationFrom1 Jan 2018 → 31 Aug 2022Funding: VLIR-UOS TEAM
- Relation between energy and redox metabolism and regulated
necrosis during EMT: an opportunity for experimental cancer
therapy.From1 Jan 2018 → 31 Dec 2022Funding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 306
- Type 1 immunity enables neonatal thymic ILC1 production(2024)
Authors: Peter Tougaard, Mario Ruiz Pérez, Wolf Steels, Jelle Huysentruyt, Bruno Verstraeten, Jessica Vetters, Tatyana Divert, Amanda Gonçalves, Ria Roelandt, Nozomi Takahashi, et al.
- Caspase inhibition modulates monocyte-derived macrophage polarization in damaged tissues(2023)
Authors: Stéphanie Solier, Michele Mondini, Lydia Meziani, Arnaud Jacquel, Catherine Lacout, Tom Vanden Berghe, Yvon Julé, Jean-Claude Martinou, Gérard Pierron, Julie Rivière, et al.
- Systematic compositional analysis of exosomal extracellular vesicles produced by cells undergoing apoptosis, necroptosis and ferroptosis(2023)
Authors: Benjamin Cappe, Mike Vadi, Eliza Sack, Ludivine Wacheul, Bruno Verstraeten, Sara Dufour, Julien Franck, Wei Xie, Francis Impens, An Hendrix, et al.
- NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis(2023)
Authors: Yves Dondelinger, Dario Priem, Jon Huyghe, Tom Delanghe, Peter Vandenabeele, Mathieu Bertrand
- Trial watch : chemotherapy-induced immunogenic cell death in oncology(2023)
Authors: Jenny Sprooten, Raquel S Laureano, Isaure Vanmeerbeek, Jannes Govaerts, Stefan Naulaerts, Daniel M Borras, Lisa Kinget, Jitka Fucikova, Radek Spisek, Lenka Palova Jelinkova, et al.
- Pore-forming proteins as drivers of membrane permeabilization in cell death pathways(2023)
Authors: Peter Vandenabeele, Geert Bultynck, Savvas Savvides
Pages: 312 - 333 - Apoptotic cell death in disease : current understanding of the NCCD 2023(2023)
Authors: Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A Aaronson, John M Abrams, Dieter Adam, Massimiliano Agostini, Patrizia Agostinis, Emad S Alnemri, Lucia Altucci, et al.
Pages: 1097 - 1154 - Molecular mechanisms of nemorosone-induced ferroptosis in cancer cells(2023)
Authors: Roberto Fernández-Acosta, Jurgen Caroen, Bartosz Wiernicki, Daniel Alvarez-Alminaque, Johan Van der Eycken, Peter Vandenabeele, Tom Vanden Berghe, Gilberto L. Pardo-Andreu
- RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD(2023)
Authors: Hannelore Van Eeckhoutte, Chantal Donovan, Richard Y. Kim, Thomas M. Conlon, Meshal Ansari, Haroon Khan, Ranjith Jayaraman, Nicole G. Hansbro, Yves Dondelinger, Tom Delanghe, et al.
- Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression(2023)
Authors: Emily Van San, Angela Debruyne, Geraldine Veeckmans, Yulia Y. Y. Tyurina, Vladimir A. A. Tyurin, Hao Zheng, Sze Men Choi, Koen Augustyns, Geert van Loo, Bernhard Michalke, et al.
Pages: 2092 - 2103
Patents
1 - 6 of 6
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- Targeting of Interleukin-1 and -18 in treatment of septic shock (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)